The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. But the results add to evidence that GLP-1 drugs like Ozempic might help with cravings for things ...

New York, New York-- (Newsfile Corp. - February 15, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Select stocks including Alkem Labs, Cummins India, Gulf Oil and PI Industries as their company boards announced dividends for ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Lexaria Bioscience (LEXX) announces that dosing has begun in its fluorescently tagged DehydraTECH-semaglutide rodent biodistribution study. The ...

Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...

Robert F. Kennedy Jr. shared concerns on the GRAS process and claimed GLP-1s are “miracle drugs” but fell short on the drugs being a silver bullet for curing the obesity epidemic in the US ...

While GLP-1s have helped millions of Americans lose weight, patients can quickly regain the weight when they stop the medication. Researchers are now investigating a new outpatient endoscopic ...